Genoplan, is a series B startup based in Korea, Japan and Singapore with accumulated funding of US18 million. It provides a B2B2C genetic & health analytics platform for Insurers in Asia.
Through our technology in genetic analysis, we analyzes user’s saliva to provide individuals with their genetic profile and personalized recommendation to lifestyle change, including diet, health food, work-out, and cosmetics.
The company was incorporated in 2014, and has operations at Seoul, Korea and Fukuoka & Tokyo, Japan, and Singapore.
Company Details
- Founded
- -
- Address
- 438 Alexandra Road, #17-02/03 Alexandra Point, Singapore,singapore 119958,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.genoplan.com/
- HQ
- Singapore, Singapore
Genoplan Asia Pacific Questions
Genoplan Asia Pacific's website is http://www.genoplan.com/
Genoplan Asia Pacific's LinkedIn profile is https://sg.linkedin.com/company/genoplanap
Genoplan Asia Pacific's industry is
Biotechnology Research
Genoplan Asia Pacific's top competitors are
Cosomil, Inc.,
Yaxie,
Shonan Health Innovation Park,
Digzyme, Inc,
Genoplan,
Sanbio,
Bgf Plantrix,
Rege Nephro Co., Ltd.,
Luca Science Inc.,
Dna Link.
Genoplan Asia Pacific's categories are Biotechnology Research
Genoplan Asia Pacific's founding year is 2014
